News

Collaborative paper published about ketogenic metabolic therapy for long-COVID recovery

August 25, 2025

Colgan, D. D.; Stadler, D. D.; Hope, A. A.; Zwickey, H.; Davenport, T. E.; Weimbs, T. Clinically Meaningful Improvements in Long COVID Symptoms Following Ketogenic Metabolic Therapy Combined with Lifestyle Interventions - A Clinical Case Report and Review of the Literature. CRCM 2025, 14 (08), 391–410.

Abstract:

Podcast by Dr. Ovadia featuring our research on polycystic kidney disease

July 08, 2025

Melina Messing receives 2025 Jared J. Grantham Research Fellowship Award

July 01, 2025

Congratulations to Melina Messing, PhD for receiving the 2025 Jared J. Grantham Research Fellowship Award to support her research in the Weimbs laboratory. Melina will study "Immune Mechanisms Underlying Efficacy of Ketogenic Metabolic Therapy in Polycystic Kidney Disease".

Collaborative paper with Virta Health published

June 06, 2025

Athinarayanan, S. J.; Roberts, C. G. P.; Phinney, S. D.; Weimbs, T.; Friedman, A. N.; Volek, J. S. Effects of a Continuous Remote Care Intervention Including Nutritional Ketosis on Kidney Function and Inflammation in Adults with Type 2 Diabetes: A Post-Hoc Latent Class Trajectory Analysis. Front. Nutr. 2025, 12. https://doi.org/10.3389/fnut.2025.1609737.

Emily Ngo chosen as UC LEADS Scholar

May 10, 2025

Congratulations to Weimbs Lab undergraduate researcher Emily Ngo who has been accepted to the University of California Leadership Excellence through Advanced Degrees (UC LEADS) program for the 2025-27 Scholar Cohort

New review article published explaining how polycystic kidney disease progression is not just driven by genetics but by nutrition and lifestyle triggers

October 31, 2024

Messing, Melina, Jacob A. Torres, Nickolas Holznecht, and Thomas Weimbs. “Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.” Nutrients 16, no. 19 (January 2024): 3281.

https://doi.org/10.3390/nu16193281

New paper published in iScience

September 27, 2024

Congratulations to all authors!

Torres, J. A.; Holznecht, N.; Asplund, D. A.; Kroes, B. C.; Amarlkhagva, T.; Haeffner, M. M.; Sharpe, E. H.; Koestner, S.; Strubl, S.; Schimmel, M. F.; Kruger, S.; Agrawal, S.; Aceves, B. A.; Thangaraju, M.; Weimbs, T. β-Hydroxybutyrate Recapitulates the Beneficial Effects of Ketogenic Metabolic Therapy in Polycystic Kidney Disease. iScience 2024, 27 (9). https://doi.org/10.1016/j.isci.2024.110773.